Cardiac Pacing and Electrophysiology

Cardiac Pacing and Electrophysiology : A Bridge to the 21st Century

Edited by  , Edited by  , Edited by  , Edited by 

List price: US$99.00

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks


This book covers aspects of new developments in the field of basic electrophysiology, cardiac pacing, implantable defibrillators and addresses socioeconomic aspects related to thse topics. The section on electrophysiology provides a comprehensive overview of basic hardware equipment, sudden death, heart rate variability, signal averaged ECG, RF catheter ablation and clinical decision making. The section on pacing includes overviews on new lead developments, pacing in cardiomyopathy, as well as VVIR & DDIR pacing and automatic mode switching. Finally the section on implantable defibrillator provides a detailed view of clinical and technical aspects of third generation devices. All chapters have been written by world experts in their fields and each chapter is fully illustrated with tables, ECG recordings and black and white photographs. The book should be of use to nurses, technicians, bioengineers, cardiologists, cardiovascular surgeons, health authorities and for all who are involved in the field of pacing and electrophysiology.
show more

Product details

  • Hardback | 456 pages
  • 160 x 238.8 x 27.9mm | 997.91g
  • Dordrecht, Netherlands, United States
  • English
  • illustrations, b&w photographs, tables
  • 079232627X
  • 9780792326274

Table of contents

Part 1 Electrophysiology: Equipment for the electrophysiology laboratory - possibilities and limitations; Vasovagal syncope - clinical presentation, classification and management; Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias; Electrophysiological particularities in arrhythmogenic right ventricular dysplasia and dilated cardiomyopathies; Classification of death in patients under antiarrhythmic treatment; Heart rate variability; Methodology and physiological basis; Heart rate variability and QT interval - their relationship with the cardiac frequency; Role of dynamic QT interval in Holter tapes to stratify risk in postmyocardial infarction patients; Heart rate variability in patients with angina pectoris; Time and frequency domain analysis of heart rate variability after myocardial infarction; Signal averaged ECG; Technical principles, possibilities and limitations; Optimizing the predictive value of the signal-averaged electrocardiogram for serious arrhythmic events in the post-infarction period; Signal-averaged analysis of the P wave - possible applications in different settings; Late potentials during acute myocardial ischemia; Radiofrequency catheter ablation in the treatment of supraventiruclar tachycardias; Anatomical versus electrophysiological approaches for ablation of the slow pathway in patients with AV nodal reentraqnt tachycardia. Part 2 Pacing: Myocardium electrode interface at the cellular level; The myocardium-electrode interface at macro level; Cardiac pacing in Europe in 1992 - a new survey. Unipolar versus bipolar leads; Single lead VDD pacing - an update; Substantial improvement of screw-in electrodes; Physiological cardiac pacing an inidividual objective; Pacemaker syndrome during atrial-based pacing; Dual chamber pacemaker therapy in cardiomyopathy; DDD rate responsive pacing, state-of-the-art; Heart rate, oxygen saturation, minute ventilation and body activity; DDDR and atrial arrhythmia. Holter and pacemaker diagnostics; Clinical relevance of histograms in the follow-up of DDDR-pacemakers; Automatic measure of the interface capacitor and the total cardiac impedance; Critical analysis of the different algorithms designed to protect the paced patient against atrial tachyarrhythmias in dual chapter pacing; Mode switching in DDDR pacing. Part 3 Defibrillators: Indication for ICD implantation and selection of patient - present and future; The optimum tilt for defibrillation; Cerebrovasomotor reactivity predicts tolerance to tiered therapy with implantable cardioverter-defribillators; (Part contents.)
show more